Ms. Portia Nkhumbuleni Ramashia | Radiation Oncology | Best Researcher Award
Ms. Portia Nkhumbuleni Ramashia, University of Johannesburg, South Africa
Ms. Portia Nkhumbuleni Ramashia is an experienced Radiation Therapist and academic, currently serving as a Radiotherapy Lecturer at the University of Johannesburg (UJ). With extensive experience in both public and private healthcare sectors, she is known for her leadership, analytical thinking, and ability to mentor colleagues in delivering high-quality oncology care. As a Research Ethics Committee Member and Departmental Research Committee Chairperson, she plays a key role in ensuring research integrity and policy adherence. Passionate about healthcare innovation and education, she supervises master’s students and actively contributes to global oncology research. ππ
Publication Profile
π Education
Ms. Ramashia holds a Master of Technology in Radiography (2017), B-Tech in Radiation Therapy (2009), and a National Diploma in Radiation Therapy (2006) from the University of Johannesburg. She is currently pursuing a PhD in Public Health at UJ, focusing on healthcare access, quality, and cancer treatment advancements. Her academic journey reflects a strong commitment to radiotherapy excellence and public health research. ππ¬
πΌ Experience
With over a decade of experience, Ms. Ramashia has excelled as a Radiation Therapy Lecturer at UJ since 2018, developing innovative teaching methodologies and supervising master’s students. She chairs research committees, ensuring compliance with faculty policies, and engages in multidisciplinary collaborations. As a Radiation Therapist, she has worked in both public and private healthcare, pioneering strategies to enhance radiotherapy access and quality. She frequently presents her research at global conferences, influencing radiotherapy practices worldwide. π₯π
π Awards & Honors
Ms. Ramashia has been recognized for her academic and research contributions, securing the NRF Black Academic Advancement Program (BAAP) Grant (2024) and being invited to the 2024 NRF Next Generation and Emerging Researchers Symposium. She has also been selected to attend the prestigious 16th HOPE Meeting with Nobel Laureates (2025). Her achievements highlight her impact on oncology research and academic excellence. π π¬